These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2285642)
21. Chronic effect of ketanserin in mild to moderate essential hypertension. Woittiez AJ; Wenting GJ; van den Meiracker AH; Ritsema van Eck HJ; Man in't Veld AJ; Zantvoort FA; Schalekamp MA Hypertension; 1986 Feb; 8(2):167-73. PubMed ID: 2935497 [TBL] [Abstract][Full Text] [Related]
22. Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension. Chiou KR; Chen CH; Ding PY; Chen YT; Ting CT; Huang JL; Chiang AH; Liu CP; Tseng CJ; Chao CT; Chang MS Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):368-76. PubMed ID: 10862446 [TBL] [Abstract][Full Text] [Related]
23. Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertension. Ruff D; Gazdick LP; Berman R; Goldberg AI; Sweet CS J Hypertens; 1996 Feb; 14(2):263-70. PubMed ID: 8728306 [TBL] [Abstract][Full Text] [Related]
24. Double-blind comparison of captopril and enalapril in mild to moderate hypertension. Vlasses PH; Conner DP; Rotmensch HH; Fruncillo RJ; Danzeisen JR; Shepley KJ; Ferguson RK J Am Coll Cardiol; 1986 Mar; 7(3):651-60. PubMed ID: 3005384 [TBL] [Abstract][Full Text] [Related]
25. Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension. Rumboldt Z; Marinković M; Drinovec J Int J Clin Pharmacol Res; 1988; 8(3):181-8. PubMed ID: 2841251 [TBL] [Abstract][Full Text] [Related]
26. A comparison of enalapril and metoprolol as initial therapy for mild to moderate hypertension. Nugent LW; Miola SR; Walker JF J Clin Pharmacol; 1987 Jul; 27(7):461-7. PubMed ID: 2821080 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. Malmqvist K; Kahan T; Dahl M Am J Hypertens; 2000 May; 13(5 Pt 1):504-11. PubMed ID: 10826401 [TBL] [Abstract][Full Text] [Related]
28. [Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy]. Beretta-Piccoli C; Amstein R; Bühler FR; Bertel O; Brunner HR; Follath F; Reutter F; Vallotton MB Schweiz Med Wochenschr; 1989 Mar; 119(12):399-406. PubMed ID: 2711155 [TBL] [Abstract][Full Text] [Related]
29. Ketanserin and captopril interaction in the treatment of essential hypertensives. Lavezzaro G; Ladetto PE; Valente M; Stramignoni D; Zanna C; Assogna G; Salvetti A Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():119-22. PubMed ID: 2285641 [TBL] [Abstract][Full Text] [Related]
30. A comparison of amlodipine with enalapril in the treatment of isolated systolic hypertension. Webster J; Fowler G; Jeffers TA; Lyons D; Witte K; Crichton WA; Wickham EA; Sanghera SS; Cornish R; Petrie JC Br J Clin Pharmacol; 1993 May; 35(5):499-505. PubMed ID: 8512762 [TBL] [Abstract][Full Text] [Related]
31. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril. Holwerda NJ; Fogari R; Angeli P; Porcellati C; Hereng C; Oddou-Stock P; Heath R; Bodin F J Hypertens; 1996 Sep; 14(9):1147-51. PubMed ID: 8986917 [TBL] [Abstract][Full Text] [Related]
32. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa. Cattin L; Da Col PG Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164 [TBL] [Abstract][Full Text] [Related]
33. Comparison of enalapril and propranolol in essential hypertension. van Schaik BA; Geyskes GG; Kettner N; Boer P; Mees EJ Eur J Clin Pharmacol; 1986; 29(5):511-6. PubMed ID: 3007162 [TBL] [Abstract][Full Text] [Related]
34. Ketanserin alone and in combination with enalapril in the treatment of essential hypertension: assessment of the haemodynamic effects. de Divitiis O; Galderisi M; Celentano A; Tammaro P; Garofalo M; Palmieri V; Crivaro M; Assogna G; Zanna C J Int Med Res; 1993; 21(3):113-25. PubMed ID: 8299854 [TBL] [Abstract][Full Text] [Related]
35. A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension. Sassano P; Chatellier G; Amiot AM; Alhenc-Gelas F; Corvol P; Ménard J J Hypertens Suppl; 1984 Dec; 2(2):S75-80. PubMed ID: 6100880 [TBL] [Abstract][Full Text] [Related]
37. Antihypertensive and metabolic effects of ketanserin in diabetic patients with mild hypertension. Beretta-Piccoli C; Salvadé G; Bachmann C; Riesen W; Zuppinger K J Hum Hypertens; 1988 Aug; 2(2):103-10. PubMed ID: 3072419 [TBL] [Abstract][Full Text] [Related]
38. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group. Zanchetti A; Omboni S Am J Hypertens; 2001 Feb; 14(2):129-34. PubMed ID: 11243303 [TBL] [Abstract][Full Text] [Related]
39. A placebo-controlled crossover study of ketanserin in elderly hypertensive patients. McCarthy ST; McCarthy GL; John SM; Gould SE Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():115-7. PubMed ID: 2285640 [TBL] [Abstract][Full Text] [Related]
40. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension. Sánchez S; Luna A; Orozco R; Velasco G Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]